An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Treatment Acquiring Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing market exists on messaging services, where groups with thousands of members share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Express Concerns
However, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could result in users injecting substances of uncertain source.
Some professionals stated the popularity for the experimental drug could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.
Several content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Service Response and Content Elimination
Based on TikTok, the service has removed problematic material and banned related keywords and search suggestions. The company stated it was committed to maintaining the service secure and investing in enhancing enforcement strategies.
Online Marketplace Operations
Research also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, filled with images of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at home.
Within moments of joining one community, a vendor posted contact information, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.
Item Details and Pricing
Inside these groups, messages display dark colored packages with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When asked how much time a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram stated it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting substances they cannot confirm. Although the research behind this drug is sound, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has previously seen patients injured by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may expose users to potentially serious health risks”.
